Pages
Files
Disclosure Ref 2024143 - CAFM contract.pdf
Freedom of information disclosure regarding corporate property/assets, ownerships and occupations, lease agreements and facilities management (CAFMSpace and Facilties management) contracts and procurement
Long Term Segregation Policy (P86)
This policy aims to provide clear guidance on the use of long term segregation, (please note the use of seclusion is covered in DCHS trust policy – (Management, Prevention and reduction of violence and aggression including physical restraint and seclusion). To ensure restrictive interventions remain proportionate, least restrictive, take account of patient preference where possible, and last for no longer than is necessary. The policy sets clinical standards to ensure compliance with the Mental Health Act 1983 and subsequent Code of Practice 2015 alongside NICE guidance NG10. To ensure robust governance arrangements that are transparent in their nature. To support the trusts ambition of reducing the use of restrictive practices. The policy aims to ensure the specific needs of all patients are met in a fair and equitable way.
Water Safety Governance Policy 1.1
Water, Water Safety Group, Legionella, Pseudomonas Aeruginosa, Legionellosis, Water Management, water flushing.
Disclosure Ref 2024148 - Maintenance Systems Contracts.pdf
Freedom of information disclosure regarding contracts for software used for maintenance management systems
Disclosure Ref 2024162 - Committee Meeting Software.pdf
Freedom of Information disclosure regarding committee meeting management software
UTC Acute Wound Care Formulary (G99)
A comprehensive evidence‐based approach to acute wound management is an essential skill set for any Emergency Clinician or Urgent Care Practitioner and this adapted version of the DCHS wound care formulary has been devised to help facilitate this. The Urgent Treatment Centre (UTC) acute wound care formulary is designed to provide Clinicians with a comprehensive guide to wound dressing products and closure within this speciality. These products were originally selected using the Derbyshire Community Dressing Formulary and Wound Care Guidelines 2018 in version 1 and have been updated in conjunction with the updated version of this for 2022 and the East Midlands Tissue Viability Group
Opportunistic Maggots Guidance (G274)
Every year during the hot weather we experience an increase in patients with opportunistic maggots in the community. This guidance is to aid assessment and management of these patients.
Disclosure Ref 202483 - IT Infrastructure.pdf
FOI disclosure regarding IT Infrastructure for desktop management, data centre, server management, networking and IT security
Corporate Framework August 2025
Corporate Framework August 2025
Venous Thromboembolism (VTE) Prophylaxis Policy (P8)
Venous Thromboembolism (VTE) is a leading cause of avoidable death in the UK. It is estimated that VTE causes in excess of 25,000 potentially preventable deaths per annum in UK hospitals – five times the estimated number of deaths each year from hospital-acquired infection. In the UK as a whole this figure is approximately 60,000 preventable deaths each year (DH, 2007). The implementation of evidence based guidelines first published by the National Institute of Clinical Excellence (NICE) in 2010 focussing on the prevention of VTE in hospitalised patients has been afforded a high priority by the Department of Health and commissioners. VTE risk assessment is a former national CQUIN indicator and is a National Quality Requirement in the NHS Standard Contract for 2019/20 (NHSE, 2019). It sets a threshold rate of 95% of adult inpatients being risk assessed for VTE on admission each month. This policy and the accompanying clinical documentation will enable clinicians to reduce mortality and morbidity associated with this VTE through screening patients admitted for day surgery or inpatient care and those attending Minor Injury Unit / Urgent Treatment Centres, educating patients and carers about preventative measures, initiating prophylactic treatment and recognising signs of VTE development.